Indian pharma sector to log 7-9% growth in FY26 despite US headwinds: ICRA

India's pharmaceutical industry is set to record healthy revenue growth of 7-9 per cent in FY26, even as challenges in the United States market continue to weigh on performance, noted rating agency ICRA in its latest sector outlook.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7iWKYxw
via IFTTT